SCIESCOPUSQ1
DIABETES OBESITY & METABOLISM
WILEY, United States
DIABETES OBESITY & METABOLISM is an academic journal published by WILEY (United States). Identifiers: ISSN 1462-8902, eISSN 1463-1326. Indexed in SCIE, SCOPUS. Metrics: JIF 5.7, CiteScore 8.8, SJR 2.251, SNIP 1.43. Subject areas: ENDOCRINOLOGY & METABOLISM. tlooto lists 4,891 papers from this journal.
CiteScore
8.80
Scopus citation metric
SJR
2.251
SCImago rank
SNIP
1.43
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1462-8902
- eISSN
- 1463-1326
- Abbreviation
- DIABETES OBES METAB
- Publisher
- WILEY
- Country
- United States
Web of Science categories
SCIEENDOCRINOLOGY & METABOLISM
Scopus ASJC categories
1310 Endocrinology2712 Endocrinology2724 Internal Medicine
Keywords
Endocrinology & Metabolism
Papers in this journal
Recent papers
- Involvement of the FTO A > T polymorphism in body composition and lipid profile changes after aerobic training in adults with overweight and obesity
2026
- Perceptions, Attitudes and Barriers to Obesity Management in Pakistan: Country-Specific Analysis From the ACTION-APAC Study.
2026
- Dose‐Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting
2026 · 1 citations
- A Type 2 Diabetes Policy Model That Predicts Remaining Life Expectancy, Quality‐Adjusted Life Expectancy and Healthcare Costs for Use in Economic Evaluation, Incorporating Equity Concerns
2026
- Type 2 diabetes subphenotypes are associated with differential outcomes after metabolic and bariatric surgery: An international multicentre retrospective cohort study
2026 · 1 citations
Most cited papers
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
2022 · 794 citations
- Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
2013 · 760 citations
- Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
2013 · 613 citations
- Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
2017 · 547 citations
- Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
2013 · 485 citations